ArticleFrontiers in pharmacology2021

CYP3A5 and UGT1A9 Polymorphisms Influence Immunosuppressive Therapy in Pediatric Kidney Transplant Recipients.

Paola Krall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.